A global water treatment company launched a patented closed-loop corrosion inhibitor to retain its top customers — but priced at 2–3x standard treatment cost, no one would buy it. For two years it sold at a negative margin or not at all. An independent formulation review found the product was overengineered and mis-engineered. We fixed the product, the cost, the price, and the launch — and sales followed within 45 days.
Global R&D had spent years developing a new closed-loop corrosion inhibitor built on patented technology. The performance was excellent — but the launch cost was so high that no customer would buy it. It landed at 2–3x the cost of standard treatment.
The product had been positioned to retain the company's top accounts. Instead, for the first two years, any sale that closed had to be booked at a negative margin just to get the product into the field.
The market opportunity was real: at the right price point, the product would be a clear leader. The performance was never the problem. The cost structure was.
The product worked well — that was never in question. The cost was trapped in raw materials and formulatory aids that closed-loop service never needed. Two failures compounded each other:
Overengineered. Raw materials in the blend were antagonistic. Rather than resolve the incompatibility, the formula had been loaded with even more material to push past the side-reactions it was creating — paying twice for one job.
Mis-engineered. Several actives were dosed for aggressive open-recirculating duty. In a closed loop — low make-up, low blowdown, stable water — that loading is simply wasted. The product had been designed against the wrong service envelope, and the test conditions had never reflected true closed-loop operation.
Correct the antagonism, right-size the actives to the actual application, and define test conditions that match reality — and the cost falls away without touching performance or the patent.
70% reduction in cost of materials — removing raw materials and formulatory aids the application never needed
70% gross margin at price equivalency to nitrite — no longer a 2–3x premium product
IP and patentability maintained — the reformulation preserved the protected technology
Side-reaction and deposition risk eliminated — by resolving the antagonistic raw materials instead of overdosing past them
Immediate sales within 45 days of the reformulated launch — after two years of near-zero uptake
Fastest-growing closed-loop product globally within 6 months — from zero to category leader
It's never a bad product — it's just the wrong market fit. Understanding the market, the customer, the technology, the chemistry, and the application is only something that comes from 25+ years of solving problems onsite at the customer and developing the specific products they need.
Free PDF Download
Get the full case study
Complete diagnosis, reformulation approach, and commercial results — one page.
Independent formulation and application review for water treatment products and the companies that make them. Cost-down reformulation. Application-fit and test-condition design. IP-safe rationalization. No chemistry sold — no conflicts of interest.